Lynch syndrome: New patient database of genetic condition aims to prevent cancer
A new database of all patients with Lynch syndrome aims to improve treatment and prevention for those at high-risk of cancer.
Oct 14, 2024
0
27
MeSH tree: C12.050.351.500.852.762.200
A new database of all patients with Lynch syndrome aims to improve treatment and prevention for those at high-risk of cancer.
Oct 14, 2024
0
27
A joint research team has announced that it is possible to detect and precisely remove metastatic lymph nodes during endometrial cancer surgery using neo-mannosyl human serum albumin-indocyanine green (MSA-ICG) and a laparoscopic ...
Oct 11, 2024
0
29
Uterine cancer is the most common type of gynecologic cancer. It's estimated that about 67,880 new cases will be diagnosed in 2024. Approximately 13,250 people will die from this disease in the U.S. in 2024, according to ...
Oct 7, 2024
0
29
A team of researchers at the University of Alberta has found that digoxin, a drug widely used to treat congestive heart failure, is an effective therapy for a rare and aggressive form of endometrial cancer.
Sep 16, 2024
0
24
There may be a way to slow the growth of endometrial cancer through targeted cancer cell therapy, according to new research from the University of Missouri School of Medicine.
Aug 21, 2024
0
33
Northwestern Medicine investigators have discovered that uterine serous carcinoma (USC) tumors in Black patients express more aggressive and immunosuppressive features than tumors in white patients, according to a new study ...
Aug 15, 2024
0
31
The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a Phase III trial.
Aug 1, 2024
0
28
Despite the fact that endometrial cancer is the most common cancer of the female reproductive organs, a significant percentage of women do not know that postmenopausal bleeding is a key warning sign of the disease.
Aug 1, 2024
0
35
A new large study led by researchers at the American Cancer Society (ACS) suggests that incidence rates have continued to rise in successively younger generations in 17 of the 34 cancer types, including breast, pancreatic, ...
Jul 31, 2024
1
95
In an editorial, published in Oncoscience titled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer," researchers Michelle Greenman, Blair McNamara, Levent Mutlu, and Alessandro D. Santin from Yale ...
Jul 15, 2024
0
28